Market Overview

UPDATE: Deutsche Bank Cuts Target to $105 on Shire PLC

Deutsche Bank lowers its target price to $105 from $116 on Buy-rated Shire PLC (NASDAQ: SHPGY) as PREVENT 2 failed to meet primary end points.

Deutsche Bank notes, "Shire announced that PREVENT 2 – one of the two Ph 3 studies on Lialda for the treatment of diverticulitis – did not meet its primary endpoint of reduction in the rate of recurrence over a two year period. While there is another trial (PREVENT 1) that will read out later this year, the co has decided not to pursue a regulatory filing for this indication at this time."

SHPGY closed at $94.75 a share on Friday.

Posted-In: Deutsche BankAnalyst Color Price Target Reiteration Pre-Market Outlook Analyst Ratings

 

Most Popular

Related Articles (SHPGY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters